Ram Pharmaceuticals - Cancer Therapy Products
Investor Relations

Our Team

Ricky Myers

Ricky Myers

Chief Executive Officer

Ricky Myers serves as the CEO of RAM Pharmaceuticals, where he leads the company’s efforts in developing innovative treatments for painful oral lesions and spearheads the Cancer Comfort Care initiative. He oversees the strategic direction of RAM’s product portfolio, including the pursuit of FDA approvals for groundbreaking therapies targeting severe oral mucositis in cancer patients. Triamdocaine™ received FDA IND approval on November 11, 2023, and is currently in Phase 2 clinical trials. With over 30 years of experience in business management and entrepreneurship, he is committed to enhancing patient care and comfort through effective pharmaceutical solutions.

Adrienne Rencic, Cheif Medical Officer of RAM Pharmaceuticals

Adrienne Rencic, M.D., Ph.D

Chief Medical Officer, RAM Pharmaceuticals

Dr. Rencic is a board-certified dermatologist and physician-scientist with more than two decades of experience spanning academic medicine, complex inflammatory and oncologic disease, biotechnology, and AI-enabled healthcare innovation. She completed her M.D. and Ph.D. at Thomas Jefferson University and her dermatology residency at Johns Hopkins Hospital, where she served as Chief Resident.

As Chief Medical Officer, she will lead the clinical development strategy for RAM’s targeted mucosal delivery platform, with an initial focus on radiation-induced acute oral mucositis in head and neck oncology.

Aaron Deves

Aaron Deves

Strategic Advisor
Aaron is an enterprising executive leader with 28 years of experience in the life sciences industry. He has a diverse background in strategic planning, brand development, marketing, market access, operations, and sales management across various sectors, including biologics, vaccines, and small molecules, at various stages of the product life cycle. His expertise extends to global commercialization and the evaluation of asset opportunities, which have led to multiple business development deals and product agreements. Aaron has directly led or played a critical role in numerous successful brand launches. Throughout his career, he has demonstrated a remarkable ability to manage complex situations and teams, earning him a reputation for excellence in the field of life sciences. Aaron is currently the Founder and CEO of Ocean Ridge Strategy Group LLC, where he provides commercial and development advisory services to Life Sciences Companies. Before founding Ocean Ridge Strategy Group, he held significant positions at leading pharmaceutical companies, including Teva Pharmaceuticals, Otsuka Pharmaceuticals, Pfizer, and Wyeth.
Scroll to Top